Rep. Tim Moore Sells UnitedHealth Group Incorporated (NYSE:UNH) Shares

Representative Tim Moore (R-North Carolina) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on September 03rd, the Representative disclosed that they had sold between $50,001 and $100,000 in UnitedHealth Group stock on August 15th.

Representative Tim Moore also recently made the following trade(s):

• Sold $100,001 – $250,000 in shares of Centene (NYSE:CNC) on 8/18/2025.
• Sold $100,001 – $250,000 in shares of Intel (NASDAQ:INTC) on 8/13/2025.
• Sold $50,001 – $100,000 in shares of Hyster-Yale (NYSE:HY) on 8/13/2025.
• Purchased $15,001 – $50,000 in shares of Hyster-Yale (NYSE:HY) on 8/12/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 8/11/2025.
• Purchased $15,001 – $50,000 in shares of UnitedHealth Group (NYSE:UNH) on 8/8/2025.
• Purchased $1,001 – $15,000 in shares of Centene (NYSE:CNC) on 8/8/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 8/8/2025.
• Purchased $15,001 – $50,000 in shares of Hyster-Yale (NYSE:HY) on 8/7/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 8/7/2025.

UnitedHealth Group Price Performance

Shares of UNH opened at $315.10 on Friday. The company has a market capitalization of $285.38 billion, a price-to-earnings ratio of 13.65, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45. The business has a 50-day moving average of $288.78 and a 200-day moving average of $374.41. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Institutional Trading of UnitedHealth Group

A number of institutional investors and hedge funds have recently modified their holdings of UNH. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the period. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the first quarter valued at about $42,000. LFA Lugano Financial Advisors SA bought a new stake in shares of UnitedHealth Group in the second quarter worth about $25,000. Finally, Copia Wealth Management bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $42,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Truist Financial lowered their target price on UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating on the stock in a research note on Wednesday, July 16th. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a research note on Monday, May 19th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $354.86.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is owned by company insiders.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.

Moore served as speaker of the House from 2015 to 2025.

Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.